He probably did. He always could have approached potential customers and made a deal with an upfront structure, or traded off an equity investment. Or sat on his hands waiting for other non-dilutive funding. He has definitely been trying to thread the needle where he can have his cake and eat it to. But at some point you end up going with your less desirable options especially if you think that those competitive footsteps in your rearview mirror are actually getting further away.
Mainly because 1) this is a strategically important area for the US, and 2) the demand seems real. If they had no customers and were simply promising massive future growth in a "build it and they will come" type way, it would be different. But given recent PRs their story that they have more interest than they can service seems absolutely real. i see an analogue to what happened in the AI space with all of the circular financing that was going on. It was in everyone's interest to get the industry over the hump, and they figured out how to do it without waiting for a couple of years for it to play out organically.
This, I think, is a real issue. Although I believe that the company will get a capital injection to offset what they need to deliver for the equity portion of the financing, how the company has managed this situation over the past 6 months has been atrocious.
They implied dilution would be relatively minimal for the near future, announced an offtake in early july, the stock starts running, it runs for 3-4 days and investors are blindsided with an offering well below the stock price with a bunch of warrants attached, the next time the CEO speaks publicly he casually mentions "of course we are going to dilute again for the IPO (which many were lead to believe could just be an "uplisting"), but concurrent with mentioning that the IPO would bring more dilution management offers no compelling reason what more capital would be used for. More offtakes, expanding with other water suppliers? No, we're just gonna execute on what we have in front of us for the next 12 months.
You can break a stock and the stock price gets anchored. that is what happened here. In recent months they have tried to change the messaging, but none of it will work until they address the equity piece.
I happen to think they will, even if it is in a manner that up until recently was their Plan B or C, so i am not gloom and doom here. But I have been less than impressed with how management has handled all of this.
$vltlf $LIB.V I think you are missing one other thing. Many of the current investors believe the company will voluntarily commit suicide. (This is one reason that getting to a Sr exchange would be beneficial, but that is besides the point).
In addition to what you mention about prices, the fact is that these are multi-year symbiotic relationships that are being negotiated. The customers, who desperately need strategically-secure supply, need to know they have a stable supplier well into the future when they enter into these agreements. With few other domestic options pricing isn't set to put your supplier out of business.
I think we have also seen evidence of what management has alluded to - these initial offtakes don't represent what the customers would really like to sign up for. They are a negotiation of what the company thinks they can supply in the near term, and the numbers will grow significantly for each customer over time. china decoupling is not going to start reversing.
So the part I think you missed in your post is the suicide part. some investors seem to think the company is like a crack addict - they will keep signing offtakes that will force them to issue equity to finance an ever growing pile of unprofitable lithium, and we get a dilution death spiral.
But why would the company do that? It would be a better option for the CEO certainly (largest shareholder) to simply raise enough capital to have a unit or two producing product for the next year and to simply wait for better market conditions. Heck, even if they lose Select exclusivity, if the economics are as bad as some seem to think, who else is going to step into that contract?
The demand is real. We are seeing evidence of that. It is captive demand in the sense they don't have a lot of other options for strategically acceptable supply at the moment. If we think lithium pricing will crush the one DLE company actually producing, how is anyone else going to enter the business?
I don't really think the company sits on the sidelines for a year and waits for better market conditions. When there is this much demand, things tend to get resolved. Do a bunch of customers present a united front to the DOE or Office of Strategic Capital and work with them to inject funding into the company to get us over this initial hump? Does a customer pay up to be prioritized in the supply chain and get access to secure lithium ahead of others? Does select or another water source help in some way because they want to see their royalty streams be realized sooner?
I'm not creative enough to know how this resolves. But I do know that when the demand is real, companies don't voluntarily commit suicide before the party even starts.
@KaiserMatty@AktienAkademie The stock is trading down here because we all know that capital is required. Dilution is expected. What investors may need to watch out for is a catalyst that changes the calculus a bit.
Yup. Although here I think the situation is nuanced. The demand seems real, the offtake’s are real. The financing term sheet, although not yet approved, is real. What is not going well is the share price cooperating. And I think that is largely a function of the larger market and the commodity price. Those are out of management control. They need to come up with a solution that is better than social media hype. I am hopeful they can.
Just means a challenging puzzle. In this case I just mean that normally large offtake agreements lead to a higher equity valuation but in our current situation the offtakes also bring an equity financing requirement - and it is that huge future demand creating the dilution uncertainty that is preventing the conditions for the success equity raise to monetize that future demand. Kind of circular.
I think they figure it out. The demand is real. But a complex financing obstacle course in the short term nonetheless
I hear you. I love the story of this company and if they can figure out the gordian knot* they are currently wrestling with the upside could be massive. One aspect that has given me pause is the extremely high percentage of uncritical cheerleading on the timeline. I mean, it’s nice to be reminded of the potential when the commodity space is in a downturn, but at some point you just end up discounting everything.
*the Gordon knot is really interesting with this company. In a bizarre way, until there is clarity on the equity piece needed to pair with the debt to make this all happen, each new offtake just makes the problem worse. More future equity financing needed creating a perception overhang with retail investors that complicates the equity raise. Perfect situation for an entity like the office of strategic capital, created precisely because China will depress prices to prevent the formation of North American competition.
My fingers are crossed for some kind of November surprise that lights the fuse with an initial capital infusion. The offtakes being signed should be enough to show someone like DOE that dumping even $50M into the company at this time could have a massive impact on American lithium supply.
$lib.v $vltlf Batteries have entered the chat!
A few things come to mind with this announcement. The first is that – we aren’t done.
This PR says that we had an MOU in place at the end of September. With the PR update in October the projected demand for 2028 included two battery customers with signed MOUs. This must have been one of them, so there is another one lurking that may drop soon.
That is only for Battery customers. The October update also noted that for industrial customers they were negotiating “definitive documents” with a customer representing 3,000 tonnes in 2028. That is a larger deal that today’s announcement even, and if you are negotiating definitive documents that deal will be announced very shortly.
The second thing to keep in mind is that the Libertystream is negotiating multi-year supply agreements with customers who have long lead time supplier qualification cycles. These agreements are sticky once entered into, and daily or weekly price fluctuations for lithium carbonate aren’t going to derail these discussions that are now underway. They panic retail investors, providing a buying opportunity, but to these players needing US lithium – not an impediment.
The third thing that comes to mind is that if you have interest in this company and aren’t buying while the price is down here – I think you are out of your mind.
$LIB.V $vltlf After watching events unfold in recent weeks and the presentation yesterday, I feel like the picture is becoming clearer with this company, at least for me. I’m not a pumper, but I like to throw my thoughts out there to crystalize my thinking.
In general, I feel that the the company is in an amazing position having a market leadership position with a technology that allows them to be the only/lowest risk provider of US lithium at a moment in time when there is a guaranteed need for US lithium coming down the pike. Market price fluctuations for lithium carbonate can depress the overall market but aren’t an existential factor for the lowest cost producer who also happens to be the only current supplier available to customers who want/need US lithium. If the company had $500 million in cash right now, they could productively put that money to work and when the capacity is online they would have customers lined up to take ALL of it.
So why is the stock price in the crapper given all they have accomplished? I think a few reasons.
- General downtrend in commodity stocks and commodity prices since March dragging everything down.
- Most investors feel they can invest in Libertystream when they are “derisked” (which means different things to different people) – and still have significant upside. Why jump in now?
- Even though a debt term sheet was signed and we are told that off-take agreements are coming, they are not finalized. And given that in the current market environment (see above) interested investors feel they can wait for the news and still get in at a price they are happy with given the recent carnage.
- And, finally, dilution. It is ironic for a stock that has attracted so many biotech investors, who are happy to be in a stock without the regulatory overhand and other associated games, we find ourselves in a classic biotech situation. After releasing great data everyone knows the biotech needs to raise, and often the stock price rise is muted until that is sorted out. We have that problem now with the IPO.
The company has an interesting problem to soIve in the short term. Off take customers want certainty the company will be able to build the supply before committing. The company needs off-take agreements to tap into the debt they have put together (extremely impressive for a company at this stage!). The market wants to see the off-takes and debt in place to derisk the stock and raise the price sufficiently so that the equity can be brought in to compliment the debt. The company is hamstrung because they are limited in the statements you can make about future prospects and projections while the S1 is confidential.
I think when Alex drew this up earlier in the year, the expectation was that some off-takes and a debt agreement would have the stock be multiples higher than it is now, and this would all be simpler.
Bad news is that is not where the market is currently.
The good news? There is plenty. This market conditions are going to hurt potential competitors 2X more than they affect Libertystream. The customer demand is there and they have nowhere else to go. Interest rates seem to have topped. The election is about to be behind us and even if there is a change in congress this technology is orders of magnitude more attractive to democratic leadership than lithium mines will be.
It is going to happen. There is a forest full of dry kindling sitting there and once we get the first spark, this will build on itself to create a raging hot fire.
The presentation yesterday was interesting for some of the crumbs that were left related to what the spark could be as it relates to solving our very short-term challenge.
With respect to the equity needed to pair with the debt, that could be “Customers paying to move to the head of the line” or “feedstock producers moving the head of the line”.
I think they are going to be strategic about this. This is not the biotech that will raise at whatever price necessary because you need to do it tomorrow. Alex noted “we aren’t going to make decisions about going onto the Nasdaq until we start converting our customer pipeline”
I was later than many to start buying into this stock. After the recent price drop I have loaded up and am now ready for the future.
$vltlf $lib.v
The "rule" that Friday AH news is bad applies when you are reporting the actual news itself. Not the case here. This PR is simply stating that at some point in the next month they are going to announce news. If that future PR is on a Friday AH (which I doubt), then we are screwed. This release just shows a company waiting until the last minute to reschedule for some reason.
$LIB.V $vltlf Happy to say that for me the financing news is a gamechanger. Not because it is something that I didn’t think the company was working on, but because announcing the term sheet allays my fears that the company’s recent messaging isn’t the result of a strategy different than what I assumed.
To recap my previous post, I felt that Alex’s recent messaging, very much focused on “execution” and more specifically executing on the plan to meet the minimum future required to maintain Select exclusivity, was feeding potential investor fears about dilution leading into the uplisting/IPO. Causing investors to think that taking on the dilution/warrants at 0.80 and then a few months later in an IPO simply to execute on the minimum Select commitment, was preventing the stock from appreciating to a level commensurate with the massive opportunity ahead of us.
I believe that it would be almost negligent if the actual internal plans were to do the above. The company has a head start in an industry of significant US strategic importance and if the real plan isn’t to try to capitalize on that lead and dominate the market, there is malpractice going on. My thinking was that more dilution for the uplisting is OK if it can be positioned as part of building that dominant position. Which I didn’t feel Alex was doing.
The announcement of the Term Sheet for financing put the fears to rest for me. No matter what the messaging, they are going to be able to find capital to expand outside of equity capital, and as more takeoff agreements come into play this will feed on itself, terms will get better, and any non-dilutive grant funding is just more rocket fuel to the stock.
I read the notes from the call Bill the IR person had with some investors, and he is messaging the way I wanted Alex to message last month around the previous raise. We will get a string of news, including more offtakes, leading into the IPO along with a debt package that will present a roadmap to a much bigger opportunity than simply meeting the Select minimums.
I already owned about 1% of the company but I will be adding as much as I can before news of more agreements hit in the coming weeks.
$Lib.v $VLTLF I agree with this take. I’ve got a lot in this company and am disappointed in how this has been handled. There are two ways to grow a company like this.
The first is to move forward cautiously, bootstrapping success, letting the stock price run, and minimizing dilution along the way and become a “story” stock that positions the company to “go big” at some point in the future. Dilution is minimized until the MC can support the capital needed to go big. If done well, the stock price can get well ahead of the fundamentals.
The other way to do it is to try to capitalize on the head start and that you have to attempt to dominate the future market. Everything is compressed and you try to go bigger earlier. To do this your messaging needs to match, and you really have to be selling the future to keep dilution even remotely reasonable.
Alex has been stuck between these two approaches and it has damaged the stock. His messaging this year strongly implied that their demonstrated success and ultimately off-take agreements would enable non-dilutive funding to compliment any equity funding that was required.
And, when he finally gets the holy grail – an offtake agreement, what does he do? Some vague language in a PR about how important 2-year fixed pricing is to potential capital partners, then immediately kills what was building momentum in the stock price by taking on dilution at a price that is essentially the low point for the stock this calendar year with a warrant kicker as well.
And then immediately pivots his public messaging to say “we’re gonna do it again with an IPO in a few months”. Not to build a future bigger than anyone is currently thinking about, but simply so we can execute on our Select commitments. We are all about “execution” now.
The way out of this is to string together a bunch of meaningful PRs including new off-take agreements leading up to the IPO, and they need to make sure whatever bank they use for the IPO is also bringing a debt package to the table to support future growth.
@cornrollio@MeyerMtg@Gantosj This is it. There better be a plan to raise the price in the lead up to the IPO with significant news releases. Usually that's the game - need to see if they can play it
@cornrollio@Gantosj I wasn't happy with the price of the recent raise and prefer as little dilution as possible. While I do expect additional IPO dilution, there will be a cadence of newsflow leading up to it that will 1) increase the price and 2) significantly increase the NT market potential.
🚨 LMAO! A DoorDash driver was just asked if the White House is a good tipper
DRIVER: "Ummm..."
POTUS: "WAIT!" *pulls out $100 bill*
DRIVER: "Yes! Very!" 🤣🔥
$AMGN
A Phase 1 study of AMG 513 in people living with obesity was placed on clinical hold by the U.S. Food and Drug Administration (FDA). Discussions are underway on a path forward to reopen the study.
@blumberg_kenny @yachmod $srpt The FDA accepted a supplement and is working with the company on proposed label changes. I don't think status quo is an option. The company probably asked for 5, and the FDA marked it up to either 2, 3 or4.
@EasterWing2230@Bionerd51 A response is essentially an answer to the submission. In this particular case, the company asked to expand the label. The FDA could have responded essentially by saying “no, we don’t agree”, in which case the approved label would not have changed.